Provenge

(PROH-venj) A vaccine made from immune system cells collected from a patient with prostate cancer. The cells are treated in the laboratory with a growth factor attached to a protein found on prostate cancer cells. Provenge injected into patients may stimulate T lymphocytes to kill tumor cells that express the prostate protein. Also called APC8015 and Sipuleucel-T.